Alma Nurtazina

Prof. Dr. Alma Nurtazina

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
ANAlma Nurtazina
Alma Nurtazina
DKDana Kozhakhmetova
Dana Kozhakhmetova
DDDaulet Dautov
Daulet Dautov
ASAizhan Shakhanova
Aizhan Shakhanova
Vijay Kumar ChattuVijay Kumar Chattu
Vijay Kumar Chattu
Apolipoproteins (Apo) are known atherogenic factors that play important roles in many mechanisms related to coronary heart disease. The ApoB/ApoA1 ratio is a promising diagnostic tool for metabolic syndrome (MS) in different populations, though its use is not established in Kazakhstan. This study aimed to assess the relationship between MS and the ApoB/ApoA1 ratio among hypertensive patients and to evaluate its diagnostic use for identifying MS as an alternative to triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C). A cross-sectional study was conducted in 800 eligible men and women with primary hypertension from April 2015 to December 2016. Data were collected on socio-demographics, lifestyle parameters, family history of cardiovascular disease, and hypertension. Dietary Quality Score (DQS), anthropometric data, and blood pressure were recorded; ApoA1 and ApoB levels were measured in blood samples. We found a significant positive association between MS and the ApoB/ApoA1 ratio by multiple logistic regression, as shown by a linear trend of increase of the odds ratio (OR) for MS across the quartiles of ApoB/ApoA1 (p < 0.0001). ROC analysis revealed diagnostic significance of the ApoB/ApoA1 ratio for MS, and comparative ROC analysis demonstrated equal diagnostic value of ApoB/ApoA1 ratio and TG levels (AUC = 0.71 (95% CI 0.69; 0.74) and 0.72 (95% CI 0.69, 0.76), respectively), which was significantly higher than those of HDL, ApoA1, ApoB (AUC = 0.27 (95% CI 0.23; 0.31), AUC = 0.37 (95% CI 0.33; 0.41), AUC = 0.67, (95% CI 0.63; 0.71), respectively). The diagnostic value of the ApoB/ApoA1 ratio in Kazakhs with MS appeared to equal that of TG and was significantly higher than that of HDL-C. Adjusting for gender, smoking, and DQS significantly strengthened the association between MS and the ApoB/ApoA1 ratio in the Kazakh population.

12 May 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
ANAlma Nurtazina
Alma Nurtazina
DKDana Kozhakhmetova
Dana Kozhakhmetova
DDDaulet Dautov
Daulet Dautov
NKNurzhanat Khaidarova
Nurzhanat Khaidarova
Vijay Kumar ChattuVijay Kumar Chattu
Vijay Kumar Chattu
Dyslipidemia plays an essential role in chronic kidney disease (CKD). The role of lipids and lipoproteins in the early pre-disease state of CKD in hypertensive patients is still unclear. The study aimed to evaluate the relationship between early renal dysfunction and lipid profile parameters among hypertensive patients in Kazakhstan. From April 2015 to December 2016, 800 Kazakh males and females with primary hypertension who met the inclusion criteria were included in this cross-sectional study. Data were collected on socio-demographics, lifestyle parameters, family history of cardiovascular disease, and hypertension. Additionally, Dietary Quality Score (DQS), anthropometric data, and blood pressure were recorded. Laboratory blood measurements included eGFR (estimated glomerular filtration rate), lipid profile parameters such as Apolipoprotein B, A1, HDL-C, LDL-C, and TG. We found a linear relationship between early renal dysfunction and LDL-C, Apolipoprotein B, and Apolipoprotein B/A1 ratio, which was in all cases negative and small (r = −0.27, −0.23 and −0.16, respectively). Apolipoprotein A1, HDL-C and TG have not revealed a linear relationship with GFR (r = −0.06, r = −0.06, and ρ = −0.045, respectively). The multicollinearity test restricted the linear model to Apolipoprotein B only. Further linear regression analysis confirmed an inverse significant linear association between eGFR and Apolipoprotein B. Age, DQS, and income appear to be positive confounding factors, significantly fitted the final model. ROC analysis had proven the predictive power of Apolipoprotein B in pre-CKD eGFR decline before and after adjustment for age, DQS and income (AUC = 0.62 and AUC = 0.77, respectively). For differentiating non-diabetic subjects with and without pre-CKD eGFR decrease, 1.05 g/L and 0.98 g/L are likely to be optimal cutoff points in males and females, respectively. These findings will help early prediction of renal dysfunction and contribute to a more accurate estimation of CVD risk.

27 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ANAlma Nurtazina
Alma Nurtazina
IVIvan Voitsekhovskiy
Ivan Voitsekhovskiy
MTMaxat Toishimanov
Maxat Toishimanov
DDDaulet Dautov
Daulet Dautov
KKKairat Karibayev
Kairat Karibayev
ADAltay Dusupov
Altay Dusupov
Background/Objectives: Metabolic syndrome (MS) is a collection of metabolic disorders that include insulin resistance, central obesity, dyslipidemia, and hypertension. The prevalence of MS affects 20–30% of adults worldwide, leading to serious health, social, and economic issues. Mitochondrial dysfunction, characterized by mitochondrial DNA (mtDNA) mutations and altered dynamics, plays a pivotal role in MS by impairing glucose oxidation. B vitamins are crucial for optimal mitochondrial function and overall metabolic processes, particularly within the context of MS. This study aims to investigate the associations between plasma concentrations of B vitamins and the risk of MS within the Kazakh population. Methods: In this case-control study, biochemistry measurements included serum fasting glucose, HbA1c, creatinine, and lipid profile parameters. The sample comprised individuals who agreed to participate in the investigation and at the Semey polyclinic between December 2022 to March 2024. A total of 190 Kazakhs aged 35–65 years old, including 104 subjects with MS and 86 without MS, took part in the study. Results: In a comparative analysis of serum vitamin B levels against established reference ranges, the following results were observed: 95% of participants exhibited vitamin B2 levels at the lower limit of normal, while 4.59% were classified as low. For vitamin B3, 95.77% showed low levels, with only 4.23% in the normal range. Vitamin B6 levels were low in 76.02% of participants. In contrast, 92.82% had normal serum levels of vitamin B9. Regarding vitamin B12, 38.82% had normal levels, 59.41% had elevated levels, and 1.76% were classified as low. Among the evaluated vitamins, only vitamin B2 showed a significant correlation with the risk of developing MS, with an OR of 1.79 (95% CI 1.003, 3.19, p = 0.05). Conclusions: Relatively elevated serum levels of vitamin B2 at the lower limit of the normal range are associated with a 1.8-fold increased risk of developing MS.

7 July 2021 in Sleep and Vigilance
Verified
Journal Article
Closed access
PDF file
Vijay Kumar ChattuVijay Kumar Chattu
Vijay Kumar Chattu
TSThankam S. Sunil
Thankam S. Sunil
SSSagar Santaji
Sagar Santaji
VDVeena V. Desai
Veena V. Desai
LGLalit Garg
Lalit Garg
Seithikurippu R. Pandi-PerumalSeithikurippu R. Pandi-Perumal
Seithikurippu R. Pandi-Perumal

14 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ANAlma Nurtazina
Alma Nurtazina
IVIvan Voitsekhovskiy
Ivan Voitsekhovskiy
MTMaxat Toishimanov
Maxat Toishimanov
DDDaulet Dautov
Daulet Dautov
KKKairat Karibayev
Kairat Karibayev
ADAltay Dusupov
Altay Dusupov
This research is funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant AP14871855).

6 June 2026 in Health Promotion Perspectives
Verified
Journal Article
Closed access
PDF file
Vijay Kumar ChattuVijay Kumar Chattu
Vijay Kumar Chattu
Nidhi NagabhatlaNidhi Nagabhatla
Nidhi Nagabhatla
ANAlma Nurtazina
Alma Nurtazina
PLPhilippe De Lombaerde
Philippe De Lombaerde
ADAltay Dyussupov
Altay Dyussupov
Central Asia faces mounting challenges from emerging infectious diseases, antimicrobial resistance, and food insecurity. This article examines regional cooperation in the One Health approach as a transformative strategy for strengthening regional health security through Regional Health Diplomacy (RHD). The Central Asia One Health Framework for Action represents a paradigmatic shift from fragmented national health strategies to an integrated regional approach. We argue that ‘RHD’ serves as the critical catalyst for implementing the One Health Framework. We call for the strategic implications to extend beyond health outcomes to encompass broader regional integration, establishing Central Asia as a pioneer in multi-sectoral health governance and a potential knowledge hub for One Health implementation.